PATH | VRL
Menu

Cost-Effectiveness of Rotavirus Vaccination in Ghana: Examining Impacts From 2012 to 2031

Ghana introduced rotavirus vaccination as part of routine immunization in 2012, and it has been shown to be effective in reducing disease burden in children under five years. Ghana’s transition from low to lower-middle income status in 2010 implies fewer resources from Gavi, the Vaccine Alliance, as well as other major global financing mechanisms for Ghana in the future. This article, published in Vaccine, reports results of a study that aimed to estimate the health impact, costs, and cost-effectiveness of rotavirus vaccination in Ghana from introduction to beyond the Gavi transition. The results show that continued rotavirus vaccination will be highly cost-effective, even for the period during which Ghana will assume responsibility for purchasing vaccines after transitioning from Gavi support.

Author: Nonvignon J, Atherly D, Pecenka C, et al.

Published: 2017

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Nonvignon J, Atherly D, Pecenka C, et al. Cost-Effectiveness of Rotavirus Vaccination in Ghana: Examining Impacts From 2012 to 2031. Vaccine. 2017;Early Online Publication.

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Immunization financing, Disease/vaccine specific information

Regions: Africa